Malignant Neoplastic Disease
5 clinical trials · Condition
◉ Watch Malignant Neoplastic Disease
| Record | Firm | Date |
|---|---|---|
| Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14) (NCT04975256) | Mirati Therapeutics Inc. | 2021-07-28 |
| Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2) (NCT04330664) | Mirati Therapeutics Inc. | 2020-04-07 |
| Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1 (NCT03785249) | Mirati Therapeutics Inc. | 2019-01-15 |
Track Malignant Neoplastic Disease automatically
Every clearance here is in the API, with alerts when new ones post.